17 Aug 2023
The Constitutional Court, upon the appeal of Trabzon 2nd Criminal Court of First Instance, took into consideration the institution of Deferment of the Announcement of the Verdict (“DAV”) and decided to annul all provisions regarding it. DAV, which is […]
21 Jul 2023
The Regulation covers the market control activities of (i) the human medicinal products that are licensed or authorized by the Agency, (ii) the active substances used in their production, (iii) foods having special medical purposes. Magistral medicines are not […]
23 Jun 2023
The Guideline on Import Applications and Marketing Authorization (“Guideline“) prepared by the Turkish Medicines and Medical Devices Agency (“Agency“) and entered into force on 29 August 2022 has been updated. The updated Guideline entered into force on 05 June […]
9 May 2023
The purpose of the Guideline is to determine the procedures and principles regarding the withdrawal and recall of medical devices and in vitro diagnostic devices from the market, and the duties, authorities and responsibilities of Turkish Medicines and Medical […]
14 Mar 2023
1. Intellectual Property Rights and Granting Procedure 1.1 Types of Intellectual Property Rights The Turkish legal system provides for “patents” and “utility models” for the protection of inventions. Both of these forms of protection are based on statutory law, […]
1 Mar 2023
The Communique on Turkish Food Codex Edible Casein and Caseinate (“Communique“), issued by the Ministry of Agriculture and Forestry has been published in the Official Gazette on 13.12.2022 and entered into force on the same day. With the Communique […]
16 Jan 2023
The Regulation on E-Commerce Intermediary Service Providers and E-Commerce Service Providers (“Regulation”) was published in Official Gazette dated 29 December 2022 and numbered 32058. Most of the E-Commerce Regulation’s provisions are effective as of 1 January 2023, while remaining […]
28 Oct 2022
Turkish Pharmaceuticals and Medical Devices Agency (“TITCK”) Medicine Audit Agency published the Guideline for the Risk-Based Good Clinical Practice Audits (“Guideline”) on 8 August 2022. The Guideline aims to define and standardize the processes related to risk-based good clinical […]
30 Sep 2022
Amendments to the Clinical Trials of Pharmaceuticals and Biological Products Regulation (“Amendment Regulation”) is introduced in Official Gazette dated 6 July 2022 and numbered 31888. The amendments were made with the purpose that the Turkish Medicines and Medical Devices […]
24 Aug 2022
Draft Guideline on Health Statement (“Draft Guideline”) has been published on 20 June 2022, which has been prepared by the Turkish Medicines and Medical Devices Office (“Office”). It has been stated that the opinions on the Draft Guideline should […]
